Evidence map›Paper›PMID 40644610›Full record

ArticleBlood advances2025

Hybridization capture long-read sequencing and de novo assembly of homologous haplotypes: a comprehensive hemophilia test.

Boyan Liu, Ruixia Xu, Siqian Ma, Mengnan Gu, Lingyin Kong, Lu Zhou, Haoning Liu, Shujin Chen, Yuyan Yang, Ziqiang Yu and 2 more

Abstract read
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Boyan LiuHematology Department, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0009-0004-1957-5426
Ruixia XuBasecare Medical Device Co, Ltd, Suzhou, China.
Siqian MaHematology Department, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0009-0006-6258-2706
Mengnan GuBasecare Medical Device Co, Ltd, Suzhou, China.
Lingyin KongBasecare Medical Device Co, Ltd, Suzhou, China.
Lu ZhouHematology Department, Affiliated Hospital of Nantong University, Nantong, China.
Haoning LiuHematology Department, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.
Shujin ChenHematology Department, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.
Yuyan YangBasecare Medical Device Co, Ltd, Suzhou, China.
Ziqiang YuNational Clinical Medical Research Center of Blood Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Bo LiangBasecare Medical Device Co, Ltd, Suzhou, China.
Miao JiangHematology Department, The Fourth Affiliated Hospital of Soochow University, Suzhou, China.ORCID 0000-0002-4929-4885

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractHemophilia is an X-linked bleeding disorder caused by defects in the F8 or F9 genes. Given the wide variety of F8 variants, conventional genetic testing typically requires a combination of multiple methods, and detecting rearrangements in the intron 22 homologous regions (int22hs) remains a challenging task. In this study, we developed a comprehensive hemophilia testing program using the PacBio long-read sequencing (LRS) platform. Experimentally, we established a standard operating procedure for hybridization capture LRS (hc-LRS), which generates reads longer than 5 kilobases. Analytically, we used a suite of bioinformatics tools to identify variants associated with hemophilia, including the detection of int22h-related rearrangements through de novo assembly of homologous haplotypes. Our approach successfully identified pathogenic variants in patients with, and carrier of, hemophilia, encompassing both single-nucleotide variants and structural variations, with full concordance to validated methods. Moreover, the program identified complex int22h rearrangements in several samples, which were previously difficult to detect using traditional techniques. Compared with conventional methods, hc-LRS is more cost-effective, convenient, and capable of detecting various variants in a single test. This approach provides a powerful tool for the genetic diagnosis of hemophilia, particularly in patients with unknown genetic backgrounds or complex variants. In conclusion, our comprehensive testing program represents a significant advancement in the genetic diagnosis of hemophilia.

Indexed as

Genetic TestingHaplotypesHemophilia AComputational BiologyFactor VIIIHigh-Throughput Nucleotide SequencingHumansIntronsPolymorphism, Single NucleotideSequence Analysis, DNAFactor VIII

Identifiers

PMID40644610
PMCPMC12506472

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.